Blood Test Identifies Risk of Nonalcoholic Fatty Liver Disease
Researchers have identified a noninvasive biomarker that can identify patients at risk of NAFLD complications using a simple blood test.
Category: Diabetes & Metabolic Diseases
Diabetes & Metabolic Diseases
Latest
Diabetes & Metabolic Diseases
Latest
Genfit, LabCorp to Commercialize a Novel Diagnostic for Liver Disease
LabCorp will develop and commercialize a blood-based molecular diagnostic test powered by NIS4 technology to help identify patients with at-risk nonalcoholic steatohepatitis.
Diabetes & Metabolic Diseases
Latest
FDA Clears Glucose Meter for Use with Critically Ill Patients
Nova Biomedical, Waltham, Mass, has received FDA clearance for its StatStrip Xpress glucose hospital meter system to be used in all hospital and professional healthcare settings.
FDA Approves First Blood Glucose Monitoring System for All Hospital Settings
The StatStrip Glucose hospital meter system from Nova Biomedical is the first blood glucose monitoring system to receive FDA clearance for use throughout all hospital and professional healthcare settings, including intensive care settings, and the only FDA-cleared system for the detection and management of dysglycemia throughout all professional healthcare settings, including critical care.
Read More
Blood Glucose and Infections
Although most patients are unaware of their diabetic status when they are admitted to the hospital, having a high blood glucose level is an important risk factor for healthcare-associated infections.
Read More
HbA1c Test Earns National Certification
Carolina Liquid Chemistries Corp has announced that its hemoglobin A1c glucose test has received certification by the National Glycohemoglobin Standardization Program.
Read More
Glucose, Under Analysis
FDA has recently proposed creating two distinct standards for professional-use and home-use glucose meters for diabetic patients.
Read More
Point-of-Care Test Detects Early-Stage Diabetes Complications
The NC-stat DPNCheck from NeuroMetrix is a rapid, quantitative test designed to detect diabetic peripheral neuropathy early enough to allow physicians to select appropriate treatment.
Read More
HbA1c Test Receives FDA Clearance
Abbott Laboratories has received 510(k) clearance for the Architect Clinical Chemistry Hemoglobin A1c test, a tool to aid physicians in diagnosing and monitoring diabetes.
Read More
National Diabetes Coalition Advises Caution on New Population Survey
Asian Americans at risk for obesity related disorders.
Read More
Diabetes Tests Oft Times Not Being Ordered or Used Properly
A study suggests improved communication is needed between the lab and the clinician on when to follow up with a patient who has a significant change in HbA1c.
Read More
Atherotech Adds Trio of Genetic Tests to Cardiometabolic Test Menu
Warfarin, Plavix sensitivity tests, and thrombophilia risk test provide personalized risk assessment, diagnosis, and treatment.
Read More
Mexican American Youth Show Sighs of Metabolic Syndrome: Early Screening Critical to Reduce Risk of Future Diabetes, Heart Disease
The findings of a new study by Texas Biomed scientists in San Antonio argue for early screening and intervention to delay or avoid chronic health problems as these children age.
Read More
FDA Approves First A1c Test Labeled for Diagnosing Diabetes
The HbA1c tests, or A1c tests, currently on the market are FDA-cleared for monitoring a patient’s blood glucose control, but not for diagnosing diabetes, says the FDA.
Read More
Panel Backs Status Quo, Two-Step Diagnostic Approach for Gestational Diabetes Mellitus
While many other countries and respected organizations support a one-step approach for testing pregnant women, the NIH urges adhering to a two-step approach until it is shown to be less advantageous.
Read More
Diabetes Epidemic: Increasing threat to our health care system
This article discusses the crisis of the diabetes epidemic, POC glucose testing, SMBG, the controversy over using POC glucose monitors for diagnosis, and more.
Read MoreIndependent Panel to Present Findings on Diagnosing Gestational Diabetes Mellitus
To better understand the benefits and risks of various screening and diagnostic approaches, the NIH is convening a Consensus Development Conference from October 29 to 31 to assess the available scientific evidence.
Read MoreGuidelines Suggest Two-Stage Strategy to Identify Diabetes Risk
The strategy consists of a risk assessment, followed, where necessary, by a blood test to confirm whether people have the disease, or are at high risk of developing it.
Read More